RobotDreams

30/01/2026

RobotDreams Pictures presents...

RobotDreams® is redefining diagnostics. We make the invisible visible – using AI to detect diseases before they cause harm.Diagnostics today are slow, expens...

21/09/2025

We are honored to be selected as semi-finalists at EPIC 2025 – Hong Kong’s flagship innovation & technology event organized by Hong Kong Science Park!

This November, we’ll be heading to Hong Kong, joining some of the world’s most promising startups for the chance to secure a share of the USD 105M targeted investment funding.

20/02/2025

We are proud to announce that RobotDreams® GmbH has been awarded the Austria Wirtschaftsservice (AWS) Seedfinancing – Deep Tech grant!

This funding will play a crucial role in helping us advance our AI-based cardiovascular diagnostic technology from applied research to market-ready solutions. With this support, we’ll continue pushing the boundaries in Life Sciences, bringing our vision of revolutionizing heart attack diagnostics one step closer to reality. ❤️🧬

19/02/2025

We are thrilled to share that our startup has been selected as one of the top 18 innovations for the Innovation Award 2025 by Steirische Wirtschaftsförderung SFG

02/10/2024

In a galaxy not so far away, we're overjoyed to announce that our startup RobotDreams has joined the ranks of the Jedi finalists at HealthTech Forward this December in Barcelona! May the Force (and good health tech) be with us all!

https://healthtechchallengers.com/

23/07/2024

🌠🛸 „These aren’t the diagnostics you’re looking for...“ Unless you’re looking for cutting-edge AI innovation! RobotDreams founders have landed at the David Braley Research Institute, ready to transform ACS diagnosis. May the innovation be with us!

10/05/2024

🚀 Exciting News from RobotDreams! We're thrilled to announce that our research project has received funding from the Austrian Research Promotion Agency — FFG Forschung. Our team, in collaboration with Medizinische Universität Graz, is working on a pioneering AI technology to instantly predict Acute Coronary Syndrome (ACS) right from the first blood sample taken in emergency settings.

FFG funding and services enable risky innovative projects with various partners between science and industry. The funding programmes are financed by the Republic of Austria - specifically the Federal Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK) and the Federal Ministry of Labour and Economy (BMAW) - as well as by participating federal states, companies and research organizations.

Die FFG ist die nationale Förderagentur für die unternehmensnahe Forschung und Entwicklung in Österreich.

03/04/2024

Join us for the Startup World Cup Austria 2024 Pre-Event on 25 April 2024 at Unicorn Start-up & Innovation Hub in Graz!

🚀 invest austria and AustrianStartups previously known as the Austrian Angel Investors Association, proudly brought this prestigious competition to Austria. With over 70 participating countries, it’s a grand arena that showcases the best and the brightest in startup talent every year.

02/04/2024

Mit der Entwicklung der KI im Bereich der Medizintechnik in Kooperation mit Science Park Graz liegen wir „schwer im Trend“. Liest mehr in Just Magazin.

Am Science Park Graz liegen Geschäftsmodelle auf Basis von KI-Technologien im Trend. In der Medizintechnik bieten diese neue Möglichkeiten.

29/02/2024

We are pleased to announce that we are starting a cooperation with the Medizinische Universität Graz. The MUG is supporting us in conducting an first clinical study. We will use the blood test results of around 2,700 patients to evaluate our AI-algorithms and test new approaches.

What is the study about?
There are basically two types of myocardial infarction (ACS): ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE-ACS). STEMI is relatively easy to diagnose by sharp chest pain and an ECG in combination with a conventional troponin test. Heart attacks without ST elevation (NSTE-ACS) pose a much greater challenge, as troponin tests often produce false results. This is where we come in: our AI algorithms do not use troponin, but other properties of the blood to detect whether a heart attack is present or not. We want to prove that our AI algorithm is significantly faster and more accurate than a troponin test.

31/01/2024

We have some fantastic news to share! RobotDreams has been selected as a grant recipient in the DESIRE (Development of E-Health Solutions Improving Resilience in Europe) project by ICS Internationalisierungscenter Steiermark. This is a huge leap forward in our mission to innovate in healthcare technology.

Our project, an AI-powered software for diagnosing cardiovascular diseases through blood tests, has captured the attention and support of the European healthcare sector. With this support, we're excited to advance our AI technology, broaden our network, and contribute to the digital transformation in healthcare.

Beiträge Sechs steirische KMU profitieren von DESIRE-Direktförderung 30. Januar 2024 Sechs steirische KMU profitieren von DESIRE-Direktförderung Ihr Kontakt im ICS Karin HÖLBLING Leitung EU-Projekte T +43 316 601 776 M +43 664 8179274 E [email protected] Lisa-Maria KATHOLNIG EU-Pr...

29/12/2023

In a galaxy not so far away, we've ignited the hyperdrive with a stellar 1 million € investment, uniting forces with a council of wise masters… As we navigate through the cosmos of medical innovation, our AI-based blood diagnostics are the droids we've been looking for, ready to revolutionize healthcare. May the peace and joy of the New Year be with us all! 🎉